Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06778226 · ClinicalTrials.gov registry record

ThRombectomy In Mild Ischemic Stroke With a Visible Intracranial veSsel Occlusion

A clinical trial of Stroke, sponsored by University of Miami.

Active
Registry status
5,000
Enrollment target
3
Study locations

NCT06778226 is a study of Stroke that is active but no longer recruiting, run by University of Miami. The registered enrollment target is 5,000 participants, below the 12,005-participant average among 454 other Stroke trials with a reported enrollment target (58% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06778226, a study of Stroke, is active but no longer recruiting, sponsored by University of Miami.

ACTIVE NOT RECRUITING
Registry status
5,000 participants
Enrollment target
3
Study locations

Study Summary

The purpose of TRIMIS is to study how a medical procedure by the name of endovascular therapy compares to medical treatment alone in patients with mild stroke and a blood vessel occlusion in the brain

Conditions Studied

Stroke

Study Locations (3)

Florida

  • University of Miami - Miami

Massachusetts

  • Boston Medical Center - Boston

Rhode Island

  • Brown University - Providence

Trial Details

FieldValue
Enrollment Target 5,000 participants
Start Date 2018-01-01
Est. Completion 2026-05-01

Sponsor

University of Miami

721 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06778226

The ClinicalTrials.gov registry entry for NCT06778226 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,005-participant average among 454 other Stroke trials with a reported enrollment target (58% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 0 interventions.

NCT06778226 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, Massachusetts, Rhode Island.

Frequently Asked Questions

What is clinical trial NCT06778226 about?

NCT06778226 is a clinical study titled "ThRombectomy In Mild Ischemic Stroke With a Visible Intracranial veSsel Occlusion". The purpose of TRIMIS is to study how a medical procedure by the name of endovascular therapy compares to medical treatment alone in patients with mild stroke and a blood vessel occlusion in the brain

What is the current status of trial NCT06778226?

This trial is currently active not recruiting. The enrollment target is 5,000 participants. The study started on 2018-01-01. Estimated completion is 2026-05-01.

What conditions does trial NCT06778226 study?

This clinical trial studies the following conditions: Stroke.

Who is sponsoring clinical trial NCT06778226?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06778226 being conducted?

This trial has 3 study locations across Florida, Massachusetts, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Stroke

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.